Review: Arthritogenic alphaviruses and host type I IFN responses

Announcing a new article publication for Zoonoses journal. Arthritogenic alphaviruses, such as Ross River virus, chikungunya virus and O'nyong-nyong virus, cause endemic disease globally and are a major public health concern.

The hallmarks of arthritogenic alphavirus disease are debilitating pain, and potentially chronic inflammation of the muscles, thus influencing quality of life. The type I IFN response is a major component of the innate immune response against arthritogenic alphaviruses and is essential in inhibiting viral replication and dissemination.

Type I IFNs are induced during early stages of infection and are essential for the activation of the antiviral innate immune response. They also link the innate immune response and the activation of adaptive immunity.

The authors of this article review the host immune response, particularly that involving type I IFN, in arthritogenic alphavirus disease.

Source:
Journal reference:

Tang, P.C.H., et al. (2022) Host Immune Responses to Arthritogenic Alphavirus Infection, with Emphasis on Type I IFN Responses. Zoonoses. doi.org/10.15212/ZOONOSES-2022-0028.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Elevated antibody responses to Epstein-Barr virus linked to increased risk of multiple sclerosis